GSK to donate research fund to academic society of hepatitis.

Published: 2004-03-12 06:57:00

Updated: 2004-03-12 06:57:00

President Kim Jin-ho of GSK delivered the total 140 million won of research fund to the Korea Society of Liver (President: Dr. Seo Dong-jin) on March 9. GSK has developed a therapeutic agent for the B hepatitis viral infection for the first time over the world and donated such scholarship to the Society since 1999.

The fund will be given to 2 outstanding research papers and 3 excellent liv...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.